The present application relates, in general, to health-related data management.
In one aspect, a method related to health-related data management includes but is not limited to accepting a change to one or more health regimen data entities. The method may also include, without being limited to, accepting a selection of a linkage associated with a health regimen data entity of the one or more health regimen data entities. In addition to the foregoing, other method aspects are described in the claims, drawings, and text forming a part of the present application.
In one aspect, a system related to health-related data management includes but is not limited to circuitry for accepting a change to one or more health regimen data entities. The system may also include, without being limited to, circuitry for accepting a selection of a linkage associated with a health regimen data entity of the one or more health regimen data entities. In addition to the foregoing, other system aspects are described in the claims, drawings, and text forming a part of the present application.
In one or more various aspects, related systems include but are not limited to circuitry and/or programming and/or electro-mechanical devices and/or optical devices for effecting the herein-referenced method aspects; the circuitry and/or programming and/or electromechanical devices and/or optical devices can be virtually any combination of hardware, software, and/or firmware configured to effect the herein-referenced method aspects depending upon the design choices of the system designer skilled in the art.
In one aspect, a program product includes but is not limited to a signal bearing medium bearing one or more instructions for accepting a change to one or more health regimen data entities. The program product may also include, without being limited to, one or more instructions for accepting a selection of a linkage associated with a health regimen data entity of the one or more health regimen data entities. In addition to the foregoing, other program product aspects are described in the claims, drawings, and text forming a part of the present application.
In addition to the foregoing, various other method, system, and/or program product aspects are set forth and described in the teachings such as the text (e.g., claims and/or detailed description) and/or drawings of the present application.
The foregoing is a summary and thus contains, by necessity, simplifications, generalizations and omissions of detail; consequently, those skilled in the art will appreciate that the summary is illustrative only and is NOT intended to be in any way limiting. Other aspects, features, and advantages of the devices and/or processes and/or other subject matter described herein will become apparent in the teachings set forth herein.
The use of the same symbols in different drawings typically indicates similar or identical items.
Vendor 108 is a person and/or persons and/or entity and/or entities that may supply pharmaceutical, nutraceutical, veterinary, dietary, and/or nutritional substances, procedures, processes, and/or practices of interest. The vendor 108 may use a computer 110 to add information and channels making themselves available to provide pharmaceutical, nutraceutical, veterinary, dietary, and/or nutritional substance, procedure, processes, and/or practices of interest, via another computer or computers represented by the network 106, to, among others, the end-user 102.
Publisher 112 is a person and/or persons and/or entity and/or entities that may supply information about pharmaceutical, nutraceutical, veterinary, dietary, and/or nutritional substances procedures, processes, and/or practices of interest, and/or about authorities having expertise or claimed expertise regarding pharmaceutical, nutraceutical, veterinary, dietary, and/or nutritional substances procedures, processes, and/or practices of interest. The publisher 112 may use a computer 114 to provide such information, via another computer or computers represented by the network 106, to, among others, the end-user 102. The publisher 112 represents a wide variety of information providers, including but not limited to magazine publishers, book publishers, website maintainers, weblog proprietors, experts, research organizations, and users of the pharmaceutical, nutraceutical, veterinary, dietary, and/or nutritional substances procedures, processes, and/or practices of interest.
End-users 102, vendors 108, and publishers 112 are not necessarily mutually exclusive categories. One person, group of persons, entity, or group of entities may be categorized as an end-user 102, vendor 108, and/or publisher 112 simultaneously or at different times. End-users 102, vendors 108, and publishers 112 are exemplary parties and do not represent all users. Exemplary descriptions including the end-user 102 are not limiting and do not preclude use of an embodiment by vendors 108 and/or publishers 112.
The nesting as illustrated in
A health regimen data entity may be associated with another health regimen data entity in a variety of ways. The first health regimen data entity may be associated with the second health regimen data entity with an item of associative information associated with one or the other or both. The first health regimen data entity may be associated with the second health regimen data entity as well as with additional health regimen data entities simultaneously. The multiply-referenced health regimen data entity may actually be multiple health regimen data entities in the data structure, or it may be a single health regimen data entity with multiple items of associative information used to reference it.
Although shown for clarity in
The topic 500, “Substances/Procedures,” may include common, generic, commercial, and/or trade names and/or descriptions for pharmaceutical, nutraceutical, veterinary, dietary, and/or nutritional substances, procedures, processes, and/or practices of interest to an end-user 102.
The topic 502, “Functions,” may include one or more descriptions of functions for which the substances of the topic 500, “Substances/Procedures” may be used by humans in connection with human physical and/or mental conditions, and/or veterinary purposes.
The topic 504, “Substitutes,” may include common, generic, commercial, and/or trade names and/or descriptions for pharmaceutical, nutraceutical, veterinary, dietary, and/or nutritional substances, procedures, processes, and/or practices of interest to an end-user 102, which may be substituted to perform functions associated with the topic 502, “Functions.”
The topic 506 “Supporting Reasons,” may include explanations for the functionality of the substances/procedures and substitutes included in the topics 500, “Substances/Procedures” and 504, “Substitutes.”
The topic 508, “Supporting Authorities,” may include the identities and credentials of people and/or entities which endorse the use of substances/procedures and substitutes for various functions. The supporting authorities may include medical and/or veterinary professionals and/or experts of various kinds (“gurus”), and/or manufacturers and/or distributors of substances/procedures and substitutes. The topic 508, “Supporting Authorities,” may also include testimonials and/or reports and/or anecdotal evidence from other end-users 102, and may include descriptors of factors associated with those end-users 102 to permit manual or automatic correlation of their experience with the potential experience of the end-user 102 consulting the data structure.
The topic 510, “Supporting Literature,” may include references to published articles and/or other publicly available information, by citation and/or hyperlink and/or other reference means, e.g., referred journal articles and/or magazine articles and/or website articles, pertaining to the functionality of substances/procedures and substitutes.
The topic 512, “Extant Conditions,” may include one or more selections of descriptors that describe internal physical and/or mental and/or environmental and/or spiritual and/or metaphysical factors of interest to the end-user 102 and of possible relevance to the functionality of substances/procedures and substitutes. Internal physical factors may include body temperature, medical condition, genetic information, and/or substances/procedures or substitutes ingested or to be ingested. Mental factors may include a diagnosed mental condition, a subjective mental state, genetic information, and/or substances/procedures or substitutes ingested or to be ingested. Environmental factors may include external temperature, humidity, barometric pressure, ambient light intensity, and, for some, the date, the positions of the planets, geographical factors such as those relevant to feng shui, and/or other factors relevant to disciplines, traditions, and arts considered relevant by the end-user 102 and/or by a contributor of information to the data structure and/or by a third-party authority such as an expert or a source for acquisition. Where feasible, values for external factors may be provided to the data structure in the form of health regimen data entities representing the output of instrumentation, e.g., weather instrumentation or medical instrumentation.
The topic 514, “Sources for Acquisition,” may include identities of, contact information for, and/or channels of communication with persons and/or entities from which substances/procedures or substitutes may be purchased or otherwise acquired by the end-user 102. Such sources may pay to be included in the data structure in association with this topic.
The topic 516, “Taxonomic Classes,” may include various categories with which substances/procedures and/or substitutes may be associated, e.g. acids, derivatives from X, etc.
The topic 518, “Synergies,” may include substances/procedures, substitutes, activities, and/or extant conditions that, acting together with a substance or substitute, enhance the functionality of the substance or substitute; favorably change the amount or timing or the substance or substitute needed for the desired functionality; and/or provide one or more additional desirable functionalities beyond those associated with the substance or substitute taken by itself.
The topic 520, “Things to Avoid,” may include substances/procedures, substitutes, activities, and/or extant conditions that, acting together with a substance or substitute, detracts from the functionality of the substance or substitute; unfavorably changes the amount or timing or the substance or substitute needed for the desired functionality; and/or provides one or more additional undesirable functionalities beyond those associated with the substance or substitute taken by itself.
The topic 522, “Dosing,” may include information pertaining to the mode, amount, conditions, and/or timing of the delivery of a substance or substitute to achieve the desired functionality, along with synergies and things to avoid, e.g., 200 mg capsules of Substance A, taken twice daily when sunny and thrice daily when cloudy or raining; or once daily under any conditions no matter the weather, and never to be taken when Substance B has been taken within 24 hours. Beyond that simple example, the topic 522, “Dosing,” may include a procedure for determining an amount and/or timing for the substance to be taken, rather than a simple fixed value, along with factors that give the end-user 102 options based on probabilities and other factors such as extant conditions, e.g., when the weather is hot and the end-user 102 is feeling irritable, an option to reduce a lithium dose by one pill per day, and if that does not work, by two pills per day, but never by more than two pills per day. These options and alternatives to them may also be accessed by associations with other health regimen data entities, including, e.g., hot days, lithium, and/or irritability.
The topic 524, “Formulations,” may include information pertaining to the constituents of a substance, including but not limited to the identities of the constituents, the amounts of the constituents present per unit of the substance, and/or the method(s) for combining the constituents to form the substance. In particular, the amounts of the constituents may be represented by listing the amounts numerically, and/or by a formula or formulas from which each constituent amount may be derived either by the end-user 102 or by computational resources associated with the data structure. In an embodiment, the end-user 102 may follow items of associative information to health regimen data entities and/or additional information that provide information on the sources of formulary information, e.g., an article on an experiment, or on the instruments that provided the formulary information, e.g., an indication of what the underlying methodology of selection is at least partially based upon (e.g., animal studies, human studies, in silico studies, speculation, anecdotal information, historical accounts, traditions, cultural practices, native practices, etc.
The topic 526, “Delivery,” may include information on methods of delivery, e.g., orally by capsule, orally by liquid dose, epidermally by patch, injection by syringe, and/or internally by timed release from an implanted reservoir, and on formulations, dose sizes, and dose timings associated with various delivery methods.
The end-user 102 may search the data structure for patterns, finding correlations between health regimen data entities that would otherwise not be discoverable or that would be very difficult to discover. For example, the end-user 102 may search for effects of Substance A on skin rashes in conditions of high humidity, searching, among other health regimen data entities, those including anecdotal evidence from users of Substance A in high humidity, where the users of Substance A also had skin rashes and reported apparent effects of Substance A on those rashes. Such searches for correlations may include information and observations added to the data structure by all or any of the end-users 102, vendors 108, and/or publishers 112 using the data structure. Such searches may be used to test hypotheses about the efficacy and safety of pharmaceutical, nutraceutical, veterinary, dietary, and/or nutritional substances, procedures, processes, and/or practices of interest.
As mentioned above, end-users 102 may add health regimen data entities to the data structure to report experiences with the use of substances/procedures. For example, an end-user 102 may integrate a report of an experience, e.g., partial success with the use of Substance B for reduction of hair loss in low-humidity conditions but little success in conditions of high-humidity, by selecting pre-existing health regimen data entities with which to associate new health regimen data entities that represent relevant elements of his report, and/or by associating new health regimen data entities that represent relevant elements of his report with pre-existing annotations to pre-existing health regimen data entities added by other end-users 102 with similar reports. An end-user 102 may also add health regimen data entities representing the results of correlative searches such as those described above, e.g., by adding health regimen data entities representing the results of such a search and associating them with pre-existing health regimen data entities associated with, e.g., a Substance C used to alleviate heartburn in connection with particular dietary conditions.
In using the data structure, the end-user 102 may impose his own schema on the information searched and on the output of the search. The end-user 102 may explicitly include or exclude for search purposes health regimen data entities representing factors such as weather information or astrological information. He may include or exclude for search results reporting purposes various complexities, e.g., including tables of correlations for further study, but excluding such information and including only lists of ingredients and instructions for purposes of making a particular substance for use or lists of dosages to serve as input into medical dispensing devices, either indirectly through human input to devices or automatically through direct input of dosage information to devices.
Those having skill in the art will recognize that the state of the art has progressed to the point where there is little distinction left between hardware and software implementations of aspects of systems; the use of hardware or software is generally (but not always, in that in certain contexts the choice between hardware and software can become significant) a design choice representing cost vs. efficiency tradeoffs. Those having skill in the art will appreciate that there are various vehicles by which processes and/or systems and/or other technologies described herein can be effected (e.g., hardware, software, and/or firmware), and that the preferred vehicle will vary with the context in which the processes and/or systems and/or other technologies are deployed. For example, if an implementer determines that speed and accuracy are paramount, the implementer may opt for a mainly hardware and/or firmware vehicle; alternatively, if flexibility is paramount, the implementer may opt for a mainly software implementation; or, yet again alternatively, the implementer may opt for some combination of hardware, software, and/or firmware. Hence, there are several possible vehicles by which the processes and/or devices and/or other technologies described herein may be effected, none of which is inherently superior to the other in that any vehicle to be utilized is a choice dependent upon the context in which the vehicle will be deployed and the specific concerns (e.g., speed, flexibility, or predictability) of the implementer, any of which may vary. Those skilled in the art will recognize that optical aspects of implementations will typically employ optically-oriented hardware, software, and or firmware.
The foregoing detailed description has set forth various embodiments of the devices and/or processes via the use of block diagrams, flowcharts, and/or examples. Insofar as such block diagrams, flowcharts, and/or examples contain one or more functions and/or operations, it will be understood by those within the art that each function and/or operation within such block diagrams, flowcharts, or examples can be implemented, individually and/or collectively, by a wide range of hardware, software, firmware, or virtually any combination thereof. In one embodiment, several portions of the subject matter described herein may be implemented via Application Specific Integrated Circuits (ASICs), Field Programmable Gate Arrays (FPGAs), digital signal processors (DSPs), or other integrated formats. However, those skilled in the art will recognize that some aspects of the embodiments disclosed herein, in whole or in part, can be equivalently implemented in integrated circuits, as one or more computer programs running on one or more computers (e.g., as one or more programs running on one or more computer systems), as one or more programs running on one or more processors (e.g., as one or more programs running on one or more microprocessors), as firmware, or as virtually any combination thereof, and that designing the circuitry and/or writing the code for the software and or firmware would be well within the skill of one of skill in the art in light of this disclosure. In addition, those skilled in the art will appreciate that the mechanisms of the subject matter described herein are capable of being distributed as a program product in a variety of forms, and that an illustrative embodiment of the subject matter described herein applies equally regardless of the particular type of signal bearing media used to actually carry out the distribution. Examples of a signal bearing media include, but are not limited to, the following: recordable type media such as floppy disks, hard disk drives, CD ROMs, digital tape, and computer memory; and transmission type media such as digital and analog communication links using TDM or IP based communication links (e.g., packet links).
In a general sense, those skilled in the art will recognize that the various aspects described herein which can be implemented, individually and/or collectively, by a wide range of hardware, software, firmware, or any combination thereof can be viewed as being composed of various types of “electrical circuitry.” Consequently, as used herein “electrical circuitry” includes, but is not limited to, electrical circuitry having at least one discrete electrical circuit, electrical circuitry having at least one integrated circuit, electrical circuitry having at least one application specific integrated circuit, electrical circuitry forming a general purpose computing device configured by a computer program (e.g., a general purpose computer configured by a computer program which at least partially carries out processes and/or devices described herein, or a microprocessor configured by a computer program which at least partially carries out processes and/or devices described herein), electrical circuitry forming a memory device (e.g., forms of random access memory), and/or electrical circuitry forming a communications device (e.g., a modem, communications switch, or optical-electrical equipment).
Those skilled in the art will recognize that it is common within the art to describe devices and/or processes in the fashion set forth herein, and thereafter use engineering practices to integrate such described devices and/or processes into image processing systems. That is, at least a portion of the devices and/or processes described herein can be integrated into an image processing system via a reasonable amount of experimentation. Those having skill in the art will recognize that a typical image processing system generally includes one or more of a system unit housing, a video display device, a memory such as volatile and non-volatile memory, processors such as microprocessors and digital signal processors, computational entities such as operating systems, drivers, and applications programs, one or more interaction devices, such as a touch pad or screen, control systems including feedback loops and control motors (e.g., feedback for sensing lens position and/or velocity; control motors for moving/distorting lenses to give desired focuses. A typical image processing system may be implemented utilizing any suitable commercially available components, such as those typically found in digital still systems and/or digital motion systems.
Those skilled in the art will recognize that it is common within the art to describe devices and/or processes in the fashion set forth herein, and thereafter use engineering practices to integrate such described devices and/or processes into data processing systems. That is, at least a portion of the devices and/or processes described herein can be integrated into a data processing system via a reasonable amount of experimentation. Those having skill in the art will recognize that a typical data processing system generally includes one or more of a system unit housing, a video display device, a memory such as volatile and non-volatile memory, processors such as microprocessors and digital signal processors, computational entities such as operating systems, drivers, graphical user interfaces, and applications programs, one or more interaction devices, such as a touch pad or screen, and/or control systems including feedback loops and control motors (e.g., feedback for sensing position and/or velocity; control motors for moving and/or adjusting components and/or quantities). A typical data processing system may be implemented utilizing any suitable commercially available components, such as those typically found in data computing/communication and/or network computing/communication systems.
All of the above U.S. patents, U.S. patent application publications, U.S. patent applications, foreign patents, foreign patent applications and non-patent publications referred to in this specification and/or listed in any Application Data Sheet, are incorporated herein by reference, in their entireties.
The herein described subject matter sometimes illustrates different components contained within, or connected with, different other components. It is to be understood that such depicted architectures are merely exemplary, and that in fact many other architectures can be implemented which achieve the same functionality. In a conceptual sense, any arrangement of components to achieve the same functionality is effectively “associated” such that the desired functionality is achieved. Hence, any two components herein combined to achieve a particular functionality can be seen as “associated with” each other such that the desired functionality is achieved, irrespective of architectures or intermedial components. Likewise, any two components so associated can also be viewed as being “operably connected”, or “operably coupled”, to each other to achieve the desired functionality, and any two components capable of being so associated can also be viewed as being “operably couplable”, to each other to achieve the desired functionality. Specific examples of operably couplable include but are not limited to physically mateable and/or physically interacting components and/or wirelessly interactable and/or wirelessly interacting components and/or logically interacting and/or logically interactable components.
While particular aspects of the present subject matter described herein have been shown and described, it will be apparent to those skilled in the art that, based upon the teachings herein, changes and modifications may be made without departing from the subject matter described herein and its broader aspects and, therefore, the appended claims are to encompass within their scope all such changes and modifications as are within the true spirit and scope of this subject matter described herein. Furthermore, it is to be understood that the invention is defined by the appended claims. It will be understood by those within the art that, in general, terms used herein, and especially in the appended claims (e.g., bodies of the appended claims) are generally intended as “open” terms (e.g., the term “including” should be interpreted as “including but not limited to,” the term “having” should be interpreted as “having at least,” the term “includes” should be interpreted as “includes but is not limited to,” etc.). It will be further understood by those within the art that if a specific number of an introduced claim recitation is intended, such an intent will be explicitly recited in the claim, and in the absence of such recitation no such intent is present. For example, as an aid to understanding, the following appended claims may contain usage of the introductory phrases “at least one” and “one or more” to introduce claim recitations. However, the use of such phrases should not be construed to imply that the introduction of a claim recitation by the indefinite articles “a” or “an” limits any particular claim containing such introduced claim recitation to inventions containing only one such recitation, even when the same claim includes the introductory phrases “one or more” or “at least one” and indefinite articles such as “a” or “an” (e.g., “a” and/or “an” should typically be interpreted to mean “at least one” or “one or more”); the same holds true for the use of definite articles used to introduce claim recitations. In addition, even if a specific number of an introduced claim recitation is explicitly recited, those skilled in the art will recognize that such recitation should typically be interpreted to mean at least the recited number (e.g., the bare recitation of “two recitations,” without other modifiers, typically means at least two recitations, or two or more recitations). Furthermore, in those instances where a convention analogous to “at least one of A, B, and C, etc.” is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (e.g., “a system having at least one of A, B, and C” would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.). In those instances where a convention analogous to “at least one of A, B, or C, etc.” is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (e.g., “a system having at least one of A, B, or C” would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.).
Number | Name | Date | Kind |
---|---|---|---|
4293845 | Villa-Real | Oct 1981 | A |
4446138 | Pack | May 1984 | A |
4567185 | Sackner | Jan 1986 | A |
4838275 | Lee | Jun 1989 | A |
4847764 | Halvorson | Jul 1989 | A |
4857716 | Gombrich et al. | Aug 1989 | A |
5054493 | Cohn et al. | Oct 1991 | A |
5176285 | Shaw | Jan 1993 | A |
5279294 | Anderson et al. | Jan 1994 | A |
5300302 | Tachon et al. | Apr 1994 | A |
5307263 | Brown | Apr 1994 | A |
5324077 | Kessler et al. | Jun 1994 | A |
5495961 | Maestre | Mar 1996 | A |
5537313 | Pirelli | Jul 1996 | A |
5542420 | Goldman et al. | Aug 1996 | A |
5672154 | Sillén et al. | Sep 1997 | A |
5692502 | Alpert | Dec 1997 | A |
5700998 | Palti | Dec 1997 | A |
5710578 | Beauregard et al. | Jan 1998 | A |
5737539 | Edelson et al. | Apr 1998 | A |
5770226 | Hughes, Jr. et al. | Jun 1998 | A |
5807579 | Vilkov et al. | Sep 1998 | A |
5873369 | Laniado et al. | Feb 1999 | A |
5882931 | Petersen | Mar 1999 | A |
5907291 | Chen et al. | May 1999 | A |
5940801 | Brown | Aug 1999 | A |
5954640 | Szabo | Sep 1999 | A |
5955269 | Ghai et al. | Sep 1999 | A |
5968932 | Winokur et al. | Oct 1999 | A |
5985214 | Stylli et al. | Nov 1999 | A |
5995938 | Whaley | Nov 1999 | A |
6021202 | Anderson | Feb 2000 | A |
6024699 | Surwit et al. | Feb 2000 | A |
6035230 | Kang et al. | Mar 2000 | A |
6108635 | Herren | Aug 2000 | A |
6117073 | Jones et al. | Sep 2000 | A |
6128534 | Park et al. | Oct 2000 | A |
6139494 | Cairnes | Oct 2000 | A |
6161095 | Brown | Dec 2000 | A |
6188988 | Barry et al. | Feb 2001 | B1 |
6209095 | Anderson et al. | Mar 2001 | B1 |
6227371 | Song | May 2001 | B1 |
6287595 | Loewy et al. | Sep 2001 | B1 |
6383136 | Jordan | May 2002 | B1 |
6397190 | Goetz | May 2002 | B1 |
6421650 | Goetz et al. | Jul 2002 | B1 |
6450956 | Rappaport | Sep 2002 | B1 |
6468805 | Smith | Oct 2002 | B1 |
6497342 | Zhang et al. | Dec 2002 | B2 |
6510430 | Oberwager et al. | Jan 2003 | B1 |
6529446 | de la Huerga | Mar 2003 | B1 |
6541478 | O'Malley et al. | Apr 2003 | B1 |
6586478 | Ackman et al. | Jul 2003 | B2 |
6589169 | Surwit et al. | Jul 2003 | B1 |
6609200 | Anderson et al. | Aug 2003 | B2 |
6616606 | Petersen et al. | Sep 2003 | B1 |
6656122 | Davidson et al. | Dec 2003 | B2 |
6671818 | Mikurak | Dec 2003 | B1 |
6699193 | Crutchfield et al. | Mar 2004 | B2 |
6735593 | Williams | May 2004 | B1 |
6764831 | Cameron, Sr. et al. | Jul 2004 | B2 |
6770029 | Iliff | Aug 2004 | B2 |
6790198 | White et al. | Sep 2004 | B1 |
6833274 | Lawrence et al. | Dec 2004 | B2 |
6898761 | Anderson et al. | May 2005 | B2 |
6951545 | Smith et al. | Oct 2005 | B2 |
6955873 | Blum | Oct 2005 | B1 |
7005447 | Ahotupa et al. | Feb 2006 | B2 |
7016752 | Ruben et al. | Mar 2006 | B1 |
7029441 | Dodds | Apr 2006 | B2 |
7135616 | Heard et al. | Nov 2006 | B2 |
7136820 | Petrus | Nov 2006 | B1 |
7169432 | Tanaka et al. | Jan 2007 | B2 |
7172897 | Blackburn et al. | Feb 2007 | B2 |
7193128 | Copenhaver et al. | Mar 2007 | B2 |
7197492 | Sullivan | Mar 2007 | B2 |
7216343 | Das et al. | May 2007 | B2 |
7280975 | Donner | Oct 2007 | B1 |
7295889 | Lahteenmaki | Nov 2007 | B2 |
7312243 | Pravda | Dec 2007 | B1 |
7351739 | Ho et al. | Apr 2008 | B2 |
7376585 | Haller | May 2008 | B2 |
7379167 | Mawhirt et al. | May 2008 | B2 |
7418399 | Schaeffer et al. | Aug 2008 | B2 |
7454880 | Austin et al. | Nov 2008 | B1 |
7461006 | Gogolak | Dec 2008 | B2 |
7483839 | Mayaud | Jan 2009 | B2 |
7490085 | Walker et al. | Feb 2009 | B2 |
7502666 | Siegel et al. | Mar 2009 | B2 |
7635594 | Holmes et al. | Dec 2009 | B2 |
7844609 | Kenedy et al. | Nov 2010 | B2 |
7957984 | Vallone | Jun 2011 | B1 |
8135595 | Dalton | Mar 2012 | B2 |
20010037340 | Hawkins et al. | Nov 2001 | A1 |
20010039503 | Chan et al. | Nov 2001 | A1 |
20020016719 | Nemeth et al. | Feb 2002 | A1 |
20020023172 | Gendron et al. | Feb 2002 | A1 |
20020026111 | Ackerman | Feb 2002 | A1 |
20020027164 | Mault et al. | Mar 2002 | A1 |
20020032580 | Hopkins | Mar 2002 | A1 |
20020032583 | Joao | Mar 2002 | A1 |
20020033753 | Imbo | Mar 2002 | A1 |
20020038392 | De La Huerga | Mar 2002 | A1 |
20020047867 | Mault et al. | Apr 2002 | A1 |
20020049738 | Epstein | Apr 2002 | A1 |
20020065682 | Goldenberg | May 2002 | A1 |
20020091546 | Christakis et al. | Jul 2002 | A1 |
20020099686 | Schwartz et al. | Jul 2002 | A1 |
20020106429 | Mudar et al. | Aug 2002 | A1 |
20020111932 | Roberge et al. | Aug 2002 | A1 |
20020116225 | Morse et al. | Aug 2002 | A1 |
20020128259 | Ghazzi et al. | Sep 2002 | A1 |
20020143434 | Greeven et al. | Oct 2002 | A1 |
20020147317 | Bentsen et al. | Oct 2002 | A1 |
20020147917 | Brickell | Oct 2002 | A1 |
20020156651 | Florio et al. | Oct 2002 | A1 |
20020156683 | Stoutenburg et al. | Oct 2002 | A1 |
20020192310 | Bland et al. | Dec 2002 | A1 |
20020194221 | Strong et al. | Dec 2002 | A1 |
20020196141 | Boone et al. | Dec 2002 | A1 |
20030004403 | Drinan et al. | Jan 2003 | A1 |
20030005445 | Schein et al. | Jan 2003 | A1 |
20030010791 | Gentiluomo et al. | Jan 2003 | A1 |
20030028399 | Davis et al. | Feb 2003 | A1 |
20030032069 | Muraca | Feb 2003 | A1 |
20030032868 | Graskov et al. | Feb 2003 | A1 |
20030036683 | Kehr et al. | Feb 2003 | A1 |
20030046114 | Davies et al. | Mar 2003 | A1 |
20030069757 | Greenberg | Apr 2003 | A1 |
20030072770 | McAnalley et al. | Apr 2003 | A1 |
20030073931 | Boecker et al. | Apr 2003 | A1 |
20030082544 | Fors et al. | May 2003 | A1 |
20030086338 | Sastry et al. | May 2003 | A1 |
20030099158 | De la Huerga | May 2003 | A1 |
20030114475 | Fox et al. | Jun 2003 | A1 |
20030135388 | Martucci et al. | Jul 2003 | A1 |
20030137067 | Cooper et al. | Jul 2003 | A1 |
20030139655 | Dodds | Jul 2003 | A1 |
20030158756 | Abramson | Aug 2003 | A1 |
20030163353 | Luce et al. | Aug 2003 | A1 |
20030186001 | Khan | Oct 2003 | A1 |
20030194350 | Stamatelos et al. | Oct 2003 | A1 |
20030204412 | Brier | Oct 2003 | A1 |
20030208381 | Walter et al. | Nov 2003 | A1 |
20030219812 | Quay et al. | Nov 2003 | A1 |
20030229455 | Bevilacqua et al. | Dec 2003 | A1 |
20030233124 | Hara et al. | Dec 2003 | A1 |
20030233250 | Joffe et al. | Dec 2003 | A1 |
20030233257 | Matian et al. | Dec 2003 | A1 |
20030236683 | Henderson et al. | Dec 2003 | A1 |
20040001874 | Davidson et al. | Jan 2004 | A1 |
20040006491 | Brown et al. | Jan 2004 | A1 |
20040026447 | Badin et al. | Feb 2004 | A1 |
20040039599 | Fralic | Feb 2004 | A1 |
20040064342 | Browne | Apr 2004 | A1 |
20040078220 | Jackson | Apr 2004 | A1 |
20040078236 | Stoodley et al. | Apr 2004 | A1 |
20040084895 | Blum | May 2004 | A1 |
20040088187 | Chudy et al. | May 2004 | A1 |
20040088374 | Webb et al. | May 2004 | A1 |
20040093331 | Garner et al. | May 2004 | A1 |
20040111298 | Schoenberg | Jun 2004 | A1 |
20040116780 | Brown | Jun 2004 | A1 |
20040121767 | Simpson et al. | Jun 2004 | A1 |
20040122661 | Hawkinson et al. | Jun 2004 | A1 |
20040122707 | Sabol et al. | Jun 2004 | A1 |
20040122790 | Walker et al. | Jun 2004 | A1 |
20040138926 | Ishikawa et al. | Jul 2004 | A1 |
20040143403 | Brandon et al. | Jul 2004 | A1 |
20040146592 | Garrity et al. | Jul 2004 | A1 |
20040176984 | White et al. | Sep 2004 | A1 |
20040215486 | Braverman | Oct 2004 | A1 |
20040220498 | Li et al. | Nov 2004 | A1 |
20040221855 | Ashton | Nov 2004 | A1 |
20040225203 | Jemison et al. | Nov 2004 | A1 |
20040243437 | Grace et al. | Dec 2004 | A1 |
20040243441 | Bocionek et al. | Dec 2004 | A1 |
20040254868 | Kirkland et al. | Dec 2004 | A1 |
20050014134 | West et al. | Jan 2005 | A1 |
20050021413 | Berry et al. | Jan 2005 | A1 |
20050027570 | Maier et al. | Feb 2005 | A1 |
20050033121 | Modrovich | Feb 2005 | A1 |
20050033773 | Roberge et al. | Feb 2005 | A1 |
20050038558 | Keene | Feb 2005 | A1 |
20050038674 | Braig et al. | Feb 2005 | A1 |
20050061336 | Goetz et al. | Mar 2005 | A1 |
20050070607 | Andrus et al. | Mar 2005 | A1 |
20050075794 | Hoffman et al. | Apr 2005 | A1 |
20050080651 | Morrison et al. | Apr 2005 | A1 |
20050090718 | Dodds | Apr 2005 | A1 |
20050101841 | Kaylor et al. | May 2005 | A9 |
20050102159 | Mondshine | May 2005 | A1 |
20050113649 | Bergantino | May 2005 | A1 |
20050118202 | Yamashita et al. | Jun 2005 | A1 |
20050118241 | Landschaft | Jun 2005 | A1 |
20050147667 | Rines | Jul 2005 | A1 |
20050149354 | Cyr et al. | Jul 2005 | A1 |
20050158401 | Morris | Jul 2005 | A1 |
20050180962 | Raz et al. | Aug 2005 | A1 |
20050182653 | Urban | Aug 2005 | A1 |
20050191716 | Surwit et al. | Sep 2005 | A1 |
20050192487 | Cosentino et al. | Sep 2005 | A1 |
20050211768 | Stillman | Sep 2005 | A1 |
20050216313 | Claud et al. | Sep 2005 | A1 |
20050216390 | Snider et al. | Sep 2005 | A1 |
20050228245 | Quy | Oct 2005 | A1 |
20050240085 | Knoell et al. | Oct 2005 | A1 |
20050256745 | Dalton | Nov 2005 | A1 |
20050260610 | Kurtz et al. | Nov 2005 | A1 |
20050260679 | Kellerman et al. | Nov 2005 | A1 |
20050261255 | Serhan et al. | Nov 2005 | A1 |
20050267356 | Ramasubramanian et al. | Dec 2005 | A1 |
20050271596 | Friedman et al. | Dec 2005 | A1 |
20060010009 | Fangman | Jan 2006 | A1 |
20060010090 | Brockway et al. | Jan 2006 | A1 |
20060047538 | Condurso et al. | Mar 2006 | A1 |
20060064250 | Goldstein | Mar 2006 | A1 |
20060073099 | Frincke et al. | Apr 2006 | A1 |
20060089542 | Sands | Apr 2006 | A1 |
20060090765 | Surina | May 2006 | A1 |
20060111944 | Sirmans, Jr. et al. | May 2006 | A1 |
20060129324 | Rabinoff et al. | Jun 2006 | A1 |
20060136259 | Weiner et al. | Jun 2006 | A1 |
20060161443 | Rollins | Jul 2006 | A1 |
20060177637 | Kimura | Aug 2006 | A1 |
20060240150 | Delaney et al. | Oct 2006 | A1 |
20060248468 | Constantine et al. | Nov 2006 | A1 |
20060254580 | Chalmers et al. | Nov 2006 | A1 |
20060260679 | Aratani et al. | Nov 2006 | A1 |
20060264780 | Holmes et al. | Nov 2006 | A1 |
20060281770 | Kase et al. | Dec 2006 | A1 |
20060287891 | Grasso et al. | Dec 2006 | A1 |
20070018810 | Smythe et al. | Jan 2007 | A1 |
20070035403 | Krishna et al. | Feb 2007 | A1 |
20070065506 | Kelly et al. | Mar 2007 | A1 |
20070067186 | Brenner et al. | Mar 2007 | A1 |
20070068959 | D'Silva | Mar 2007 | A1 |
20070087048 | Abrams et al. | Apr 2007 | A1 |
20070093448 | Westermann et al. | Apr 2007 | A1 |
20070118054 | Pinhas et al. | May 2007 | A1 |
20070136092 | Jung et al. | Jun 2007 | A1 |
20070161076 | Halden | Jul 2007 | A1 |
20070192134 | Littenberg et al. | Aug 2007 | A1 |
20080097784 | Miller et al. | Apr 2008 | A1 |
20080100279 | Mohapatra et al. | May 2008 | A1 |
20080139907 | Roa et al. | Jun 2008 | A1 |
20080208027 | Heaton | Aug 2008 | A1 |
20080299013 | Trieu et al. | Dec 2008 | A1 |
20090198176 | Chavez et al. | Aug 2009 | A1 |
20100081144 | Holmes et al. | Apr 2010 | A1 |
Number | Date | Country |
---|---|---|
WO 9714393 | Apr 1997 | WO |
WO 9945354 | Sep 1999 | WO |
WO 0060362 | Oct 2000 | WO |
WO 0179529 | Oct 2001 | WO |
WO 2004082359 | Sep 2004 | WO |
WO 2005018632 | Mar 2005 | WO |
WO 2005062849 | Jul 2005 | WO |
WO 2007061838 | May 2007 | WO |
Entry |
---|
Parlante, Linked List Basics, Apr. 12, 2001, http://cslibrary.stanford.edu/103/LinkedListBasics.pdf, pp. 1-26. |
Parlante, Linked List Basics, Apr. 12, 2001, http://cslibrary.stanford.edu/103/LinkedListBasics.pdf, pp. 1-26 (Year: 2001). |
U.S. Appl. No. 11/355,517, Jung et al. |
U.S. Appl. No. 11/339,316, Jung et al. |
U.S. Appl. No. 11/314,949, Jung et al. |
U.S. Appl. No. 11/314,945, Jung et al. |
U.S. Appl. No. 11/314,764, Jung et al. |
U.S. Appl. No. 11/291,532, Jung et al. |
U.S. Appl. No. 11/291,482, Jung et al. |
U.S. Appl. No. 11/285,753, Jung et al. |
U.S. Appl. No. 11/285,500, Jung et al. |
PCT International Search Report; International App. No. PCT/US 06/44664; dated Apr. 14, 2008; pp. 1-3. |
PCT International Search Report; International App. No. PCT/US07/25379; dated May 13, 2008; pp. 1-2. |
PCT International Search Report; International App. No. PCT/US07/25417; dated May 14, 2008; pp. 1-3. |
PCT International Search Report; International App. No. PCT/US07/25417; dated May 19, 2008; pp. 1-2. |
PCT International Search Report; International App. No. PCT/US2007/025450; dated May 23, 2008; pp. 1-2. |
PCT International Search Report; International App. No. PCT/US06/47835; dated Jul. 14, 2008; pp. 1-2. |
PCT International Search Report; International App. No. PCT/ US 06/44278; 2 pages; dated Aug. 17, 2007. |
PCT International Search Report; International App. No. PCT/ US 06/44269; 2 pages; dated Sep. 18, 2007. |
Cover, Robin, ed.; “Technology Reports: General SGML/XML Applications” [see e.g. “SGML Initiative in Health Care (HL7 Health Level-7 and SGML/XML)”]; Cover Pages: Hosted by Oasis; Bearing a date of Nov. 11, 2002, printed on Nov. 16, 2005; pp. 1-95; located at: http://xml.coverpages.org/gen-apps.html. |
Goedert, Joseph, ed.; “XML Comes of Age for Data Exchange”; Health Data Management; Bearing dates of Nov. 16, 2005 and 2005, printed on Nov. 16, 2005; pp. 1-4; SourceMedia, Inc; located at: http://www.healthdatamanagement.com/html/current/CurrentIssueStory.cfm?PostID=16205. |
Guo, Jinqiu; Araki, Kenji; Tanaka, Koji; Sato, Junzo; Suzuki, Muneou; Takada, Akira; Suzuki, Toshiaki; Nakashima, Yusei; Yoshihara, Hiroyuki; “The Latest MML (Medical Markup Language) Version 2.3—XML-Based Standard for Medical Data Exchange/Storage”; Journal of Medical Systems; Bearing dates of Aug. 2003 and 2003; pp. 357-366; vol. 27, No. 4; Plenum Publishing Corporation; located at: http://lob.kuhp.kyoto-u.ac.jp/paper/200308mml23JMS/mml23JMS.pdf. |
Kahn Jr., Charles E.; De La Cruz, Norberto B.; “Extensible Markup Language (XML) in Health Care: Integration of Structured Reporting and Decision Support”; Office of Clinical Informatics; pp. 1-5; located at: http://www.amia.org/pubs/symposia/D004673.PDF. |
McDonald, Carol; Srinivas, Raghavan N.; “How Java Technology and XML Are Improving Healthcare in Brazil”; Java.sun.com; Bearing dates of Feb. 2004 and 1994-2005, printed on Nov. 16, 2005; pp. 1-9; Sun Microsystems, Inc.; located at: http://java.sun.com/developer/technicalArticles/xml/brazil/index.html. |
Smith, Stevie; “New Chip Identifies Bird Flu in Humans”; The Tech Herald.com, WOTR Limited; 2008; located at: www.thetechherald.com/article/php200813/520/new-chip-identifies-bird-flu-in-humans; Bearing a date of Mar. 25, 2008; printed on Sep. 8, 2008; pp. 1-6. |
PCT International Search Report; International App. No. PCT/US2007/025451; dated Sep. 15, 2008; pp. 1-2. |
PCT International Search Report; International App. No. PCT/US07/20272; dated Sep. 15, 2008; pp. 1-2. |
PCT International Search Report; International App. No. PCT/US07/20305; dated Sep. 11, 2008; pp. 1-2. |
PCT International Search Report; International App. No. PCT/US07/20283; dated Sep. 11, 2008; pp. 1-2. |
PCT International Search Report; International App. No. PCT/US07/14994; dated Sep. 9, 2008; pp. 1-2. |
PCT International Search Report; International App. No. PCT/US2008/007993; dated Sep. 8, 2008; pp. 1-3. |
PCT International Search Report; International App. No. PCT/US06/47451; dated Sep. 5, 2008; pp. 1-2. |
PCT International Search Report; International App. No. PCT/US06/44658; dated Aug. 29, 2008; pp. 1-2. |
PCT International Search Report; International App. No. PCT/US06/44279; dated Aug. 19, 2008; pp. 1-3. |
PCT International Search Report; International App. No. PCT/US06/44283; dated Aug. 18, 2008; pp. 1-2. |
PCT International Search Report; International App. No. PCT/US07/14266; dated Jul. 21, 2008; pp. 1-2. |
Evans, R. Scott, Ph.D. et al., “A Computer-Assisted Management Program for Antibiotics and Other Antiinfective Agents”; The New England Journal of Medicine; bearing a date of Jan. 22, 1998; pp. 232-238; vol. 338, No. 4; The Departments of Clinical Epidemiology (R.S.E., S.L.P., D.C.C., J.F.L., J.P.B.), Critical Care (T.P.C., L.K.W., J.F.O.,), and Medical Informatics (R.S.E.), LDS Hospital, Salt Lake City, UT. |
Lagally, E.T. et al.; “Integrated Portable Genetic Analysis Microsystem for Pathogen/Infectious Disease Detection”; Analytical Chemistry; bearing a date of Jun. 1, 2004; pp. 3162-3170; vol. 76, No. 11; © 2004 American Chemical Society. |
Leibovici, Leonard et al.; “A Causal Probabilistic Network for Optimal Treatment of Bacterial Infections”; IEEE Transactions on Knowledge and Data Engineering; bearing a date of Jul./Aug. 2000; pp. 517-528; vol. 12, No. 4; © 2000 IEEE. |
Mullett, Charles J. et al.; “Computerized antimicrobial decision support: an offline evaluation of a database-driven empiric antimicrobial guidance program in hospitalized patients with a bloodstream infection”; International Journal of Medical Informatics; 2004; pp. 455-460; vol. 73; Elsevier Ireland Ltd. |
Sriskanthan, N. and Subramanian, K. R.; “Braille Display Terminal for Personal Computers”; IEEE Transactions on Consumer Electronics; May 1990; pp. 121-128; vol. 36, No. 2; IEEE. |
UK Intellectual Property Office Examination Report Under Section 18(3); App. No. GB1000316.8; dated Jul. 26, 2011; pp. 1-3. |
Walt et al.; “Biological Warfare, a Host of Detection Strategies Have Been Developed, But Each Has Significant Limitations”; Analytical Chemistry; bearing a date of Dec. 1, 2000; pp. 738A-747A. |
U.S. Appl. No. 13/374,765, Jung et al. |
Krishna et al.; “Glutathione and γ-glutamyl transpeptidase are differentially distributed in the olfactory mucosa of rats”; Cell Tissue Res; bearing a date of Jul. 1992; pp. 475-484; vol. 270; Springer-Verlag. |
“Component”; IEEE Xplore Digital Library; printed on Oct. 3, 2013; 1 page; IEEE; located at: http://ieeexplore.ieee.org/xpls/dictionary.jsp?stdDiet=match_keyword&def_term=component. |
“GARLIC Nature's Amazing Nutritional and Medicinal Wonder Food”; pp. 1-32; Bearing a date of 1995, Created on Jul. 3, 2014, as provided by examiner; Woodland Publishing, Inc.; Pleasant Grove, UT. |
Sabate et al; “Handbook of Nutraceuticals and Functional Foods, Chapter 28: The Role of Nuts in Cardiovascular Disease Prevention”; pp. 1-19; Bearing a date of 2001, Created on Jul. 3, 2014, as provided by examiner; CRC Press LLC. |
“Microsoft Press Computer Dictionary: The Comprehensive Standard for Business, School, Library, and Home”; bearing a date of Nov. 1, 1993; 1 page; Edition 2; Microsoft Press; ISSN: 9781556155970 (whole book not provided). |
Roberts et al.; “Nutraceuticals: The Complete Encyclopedia of Supplements, Herbs, Vitamins and Healing Foods”; American Nutraceutical Association; bearing a date of Jan. 1, 2001; pp. 1-3 (669 pages, not provided); Perigee Trade; IBSN: 0399526323 (whole book not provided). |
Edible Science; bearing dates of 2005-2010; pp. 1-2; located at: http://www.ediblescience.com; printed on May 13, 2010. |
Fightermins; bearing a date of 2010; 1 page; located at: http://www.fightermins.com/index.jsp; printed on May 13, 2010. |
Ideal Health; “Custom Essentials”; “The Priva Test”; bearing a date of 2010; total of 5 pages; located at: http://www.idealhealth.com; printed on May 13, 2010; The Trump Network. |
I-Vita; bearing a date of 2009; 1 page; located at: http://www.mynutrapack.com/index.html; printed on May 13, 2010. |
LifeScript; bearing dates of 1998-2010; 1 page; located at: http://vitamins.lifescript.com/Begin.asp?BID=14971&PROMO=zluswiec; printed on May 13, 2010. |
Mindell, Earl, Dr.; Vitaganic “Custom-Made Multivitamins”; bearing dates of 2005-2010; 1 page; located at: http://drmindell.vitaganic.com/; printed on May 13, 2010. |
My Vitamin Clinic; bearing a date of 2010; 1 page; located at: http://www.myvitaminclinic.com/index.jsp; printed on May 13, 2010. |
MyNutraPack; 1 page; located at: http://www.mynutrapack.com/index.html; printed on May 25, 2010. |
MyVitaminRx; bearing a date of 2007; 1 page; located at: http://www.myvitaminsrx.com/CustomNutrition.aspx?ID=MoonlightSpa; printed on May 13, 2010. |
Nature Made; pp. 1-2; located at: http://www.naturemade.com/; printed on May 13, 2010. |
NutriHerb; bearing dates of 2001-2009; pp. 1-2; Nutri Herb, Inc.; located at: http://www.nutriherb.net/custom_made_to_order_herbal_vitamins_supplements.html; printed on May 13, 2010. |
Pharmative LLC; 1 page; located at: http://www.pharmavite.com/index.asp; printed on May 13, 2010. |
“Pharmavite LLC Launches New Direct-To-Consumer Company” Press Release; Pharmavite LLC; bearing a date of Sep. 4, 2009; 1 page; located at: http://www.pharmavite.com/MediaCenter/MC_PR.asp?ID=164; printed on May 13, 2010. |
Signature Supplements; bearing a date of 2009; pp. 1-2; located at: http://www.signaturesupplements.com/jsp/main/index.jsp; printed on May 13, 2010; Signature Supplements. |
Soyjoy®; bearing a date of 2010; 1 page; located at: http://www.soyjoy.com/index.aspx; printed on May 13, 2010; Pharmavite LLC. |
Total Health Nutrients; pp. 1-2; located at: http://www.totalhealthnutrients.com/ph/index.html; printed on May 13, 2010. |
VitaminID.com; bearing a date of 2010; 1 page; located at: http://www.vitaminid.com/webapp/wcs/stores/servlet/StoreView?storeId=201&langId=-1; printed on May 25, 2010; Pharmavite Direct LLC. |
Vitamins on Demand; bearing a date of 2010; 1 page; located at: http://www.vitaminsondemand.com/?gclid=CNbygPut9aACFRYhDQodyGkivw; printed on May 13, 2010. |
VitaXact; bearing a date of 2009; 1 page; located at: http://www.vitaxact.com; printed on May 13, 2010. |
Weil, Andrew, M.D.; “Dr. Weil's Vitamin Advisor & Complete Program Supplements”; bearing a date of 2010; 1 page; located at: https://www.drweilvitaminadvisor.com/drw/ecs/Va2/land_goog_08girl.html?aid=999910&aparam=TSAsGoogleApr10VA_vitamins&refcd=GO000000101882154s_vitamins&tsacr=GO3784957603&gclid=CM3NpLzm9aACFRYhDQodyGkivw; printed on May 13, 2010; Weil Lifestyle Custom Pak. |
Number | Date | Country | |
---|---|---|---|
20070112587 A1 | May 2007 | US |